What is the value of a company that has 7 consecutive quarters of exceeding its revenue guidance? For the first 6 months of 2013, MiMedx's (MDXG) revenue increased by more than 190% over its revenue for the first 6 months of 2012. Not only is this company's financial growth explosive, it is exponentially growing despite "flying with one wing": its full financial potential has not been reached as its current growth reflects sales in only 5 of 9 Medicare MACS regions in the country.
What is the value of a company that has an Average Annual Growth Rate of 328% since 2010? EBITDA at the end of 2011 indicates a loss of $6...
Only subscribers can access this article, which is part of the PRO research library covering 3,591 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: